Business Update
Pharmaceutical company completes level 1 American Depositary Receipts Program
Published in Medical Letter on the CDC and FDA, February 13th, 2005
Under approval granted by the U.S. Securities Exchange Commission, investors can now purchase Starpharma ADRs on the U.S. over-the-counter market.
Starpharma CEO John Raff described the ADR program as an important step to facilitate trading of Starpharma securities by U.S. nanotechnology investors.
"Starpharma is the first company in the world to initiate FDA (U.S. Food and Drug Administration)-approved human clinical testing of a nanotech-based drug. We also have a substantial presence in U.S....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Chronic Fatigue Syndrome
Method to identify biomarkers in chronic fatigue syndrome developed - Endocrinology
Genistein and nonylphenol increase hypothalamus volume in male rats - Immunodeficiency
Antibodies to Haemophilus and Streptococcus in IGIV products detected - Mammography
Computer-assisted mammography may improve accuracy of reading - Pertussis Diagnosis
Cutoff points for antibody levels to pertussis toxin established - Aflatoxin Exposure
Aflatoxin exposure and toxicity add to disease burden in developing countries - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
